<ARTICLE>                     5
<LEGEND>
     The Schedule Contains Summary Financial  Information Extracted From Balance
     Sheets and Statements of Income
</LEGEND>
<CIK>                         0000878616
<NAME>                        Human Pheromone Sciences, Inc.
<MULTIPLIER>                                   1
       
                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-30-1998
<PERIOD-START>                                 JAN-01-1998
<PERIOD-END>                                   JUN-30-1998
<CASH>                                            70,452
<SECURITIES>                                           0
<RECEIVABLES>                                  1,452,892
<ALLOWANCES>                                    (598,456)
<INVENTORY>                                    3,230,320
<CURRENT-ASSETS>                               4,262,192
<PP&E>                                           802,923
<DEPRECIATION>                                  (720,587)
<TOTAL-ASSETS>                                 4,344,528
<CURRENT-LIABILITIES>                          2,084,179
<BONDS>                                                0
<PREFERRED-MANDATORY>                                  0
<PREFERRED>                                    2,145,535
<COMMON>                                      17,667,024
<OTHER-SE>                                   (17,552,210)
<TOTAL-LIABILITY-AND-EQUITY>                   4,344,528
<SALES>                                        5,268,418
<TOTAL-REVENUES>                               5,268,418
<CGS>                                          1,671,273
<TOTAL-COSTS>                                  5,560,142
<OTHER-EXPENSES>                                 182,448
<LOSS-PROVISION>                                       0
<INTEREST-EXPENSE>                                21,469
<INCOME-PRETAX>                               (2,168,941)
<INCOME-TAX>                                           0
<INCOME-CONTINUING>                           (2,168,941)
<DISCONTINUED>                                         0
<EXTRAORDINARY>                                        0
<CHANGES>                                              0
<NET-INCOME>                                  (2,168,941)
<EPS-PRIMARY>                                      (0.21)
<EPS-DILUTED>                                      (0.21)